Top compounds associated with response to TMEM239


Feature Type Standardized
Nominal ANOVA
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.067 0.06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.06
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.067 0.06
mRNA tandutinib CTRPv2 pan-cancer AAC -0.067 0.06
mRNA GDC-0941 gCSI pan-cancer AAC -0.11 0.06
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.089 0.06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.06
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.06
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.07 0.06
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.075 0.06
Download CSV